GSK’s top scientist to quit, become CEO of anti-ageing start-up
GSK’s chief scientific officer, Hal Barron, will head up the Silicon Valley biotech Altos Labs.
By
Investment
Latest in
Investment
VitriVax: one-shot Covid-19 vaccines to improve global access
The biotech start-up is developing technology to compress multi-dose vaccine regimens into one thermostable shot.
By
Are competition authorities tightening the rules on pharma M&A?
The US Federal Trade Commission has initiated a multilateral working group to ensure that mergers and acquisitions in the pharma…
By
Engine Biosciences raises $43m in series A for AI drug discovery
The Asian-American biotech generates novel drugs and targets through machine learning and genomics.
By
Science park merger creates UK’s largest life sciences ecosystem
Three companies have merged to form the UK’s first nationwide life sciences ecosystem, boosting R&D and drug discovery capacity in…
ByKazakhstan pursues diversification agenda
Central Asia’s largest economy, Kazakhstan, is pressing ahead with its economic diversification agenda in the face of challenges presented by…
FDI drivers and political stability
Political stability encompasses many things, including corruption, the strength of institutions and the rule of law. It therefore must be…
Will blockchain reshape trade and investment?
Cryptocurrencies have made headlines in recent years, but it is the blockchain technology that underpins them that could alter the…